Literature DB >> 19352393

Pathology: the lottery of conventional prostate biopsy.

Gerald L Andriole1.   

Abstract

Mesh：

Year:  2009        PMID： 19352393     DOI： 10.1038/nrurol.2009.46

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Prostate biopsy: targeting cancer for detection and therapy.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2006

2.  Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.

Authors:  Gerald L Andriole; Travis L Bullock; Jay S Belani; Erica Traxel; Yan Yan; David G Bostwick; Peter A Humphrey
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

3.  Prostate saturation biopsy in the reevaluation of microfocal prostate cancer.

Authors:  L M Boccon-Gibod; N Barry de Longchamps; M Toublanc; L A Boccon-Gibod; V Ravery
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

4.  The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.

Authors:  Mesut Remzi; Yan Kit Fong; Michael Dobrovits; Theodore Anagnostou; Christian Seitz; Matthias Waldert; Mike Harik; Sybille Marihart; Michael Marberger; Bob Djavan
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

5.  Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?

Authors:  Jason W Anast; Gerald L Andriole; Tarek A Bismar; Yan Yan; Peter A Humphrey
Journal:  Urology       Date:  2004-09       Impact factor: 2.649

6.  Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer.

Authors:  Ifeanyichukwu I Megwalu; Genoa G Ferguson; John T Wei; Vladimir Mouraviev; Thomas J Polascik; Samir Taneja; Linda Black; Gerald L Andriole; Adam S Kibel
Journal:  BJU Int       Date:  2008-08-05       Impact factor: 5.588

7.  Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.

Authors:  Nicolas B Delongchamps; Gustavo de la Roza; Richard Jones; Mary Jumbelic; Gabriel P Haas
Journal:  BJU Int       Date:  2008-08-01       Impact factor: 5.588

8.  Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.

Authors:  Winston E Barzell; Myron R Melamed
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

9.  Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.

Authors:  Yousef Mazaheri; Amita Shukla-Dave; Hedvig Hricak; Samson W Fine; Jingbo Zhang; Gloria Inurrigarro; Chaya S Moskowitz; Nicole M Ishill; Victor E Reuter; Karim Touijer; Kristen L Zakian; Jason A Koutcher
Journal:  Radiology       Date:  2008-02       Impact factor: 11.105

10.  Dynamic contrast-enhanced MRI for prostate cancer localization.

Authors:  A S N Jackson; S A Reinsberg; S A Sohaib; E M Charles-Edwards; S Jhavar; T J Christmas; A C Thompson; M J Bailey; C M Corbishley; C Fisher; M O Leach; D P Dearnaley
Journal:  Br J Radiol       Date:  2009-02       Impact factor: 3.039
  10 in total
  7 in total

1.  [Prostate biopsy - an unending story].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

2.  Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens.

Authors:  E David Crawford; Kyle O Rove; Al B Barqawi; Paul D Maroni; Priya N Werahera; Craig A Baer; Hari K Koul; Cory A Rove; M Scott Lucia; Francisco G La Rosa
Journal:  Prostate       Date:  2012-11-20       Impact factor: 4.104

3.  Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies.

Authors:  Gordon R Kepner; Jeremy V Kepner
Journal:  Theor Biol Med Model       Date:  2010-06-17       Impact factor: 2.432

4.  Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.

Authors:  Michael W Hance; Krystal Dole; Udhayakumar Gopal; Jessica E Bohonowych; Agnieszka Jezierska-Drutel; Carola A Neumann; Haibo Liu; Isla P Garraway; Jennifer S Isaacs
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

Review 5.  [The long journey from palpation to biopsy : The history of diagnosing prostate cancer].

Authors:  J Konert; L Sentker; C August; M Hatzinger
Journal:  Urologe A       Date:  2021-07       Impact factor: 0.639

6.  Urothelial carcinoembryonic antigen 1 score for early detection of prostate cancer and risk prediction.

Authors:  Youdong Lin; Guihua Liu; Chun Liu; Hui Xie; Xiaoxian Wang; Yudian Huang; Long Jin; Huidan Chen
Journal:  Cancer Med       Date:  2022-03-15       Impact factor: 4.711

7.  epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.

Authors:  Eve O'Reilly; Alexandra V Tuzova; Anna L Walsh; Niamh M Russell; Odharnaith O'Brien; Sarah Kelly; Odharna Ni Dhomhnallain; Liam DeBarra; Connie M Dale; Rick Brugman; Gavin Clarke; Olivia Schmidt; Shane O'Meachair; Dattatraya Patil; Kathryn L Pellegrini; Neil Fleshner; Julia Garcia; Fang Zhao; Stephen Finn; Robert Mills; Marcelino Y Hanna; Rachel Hurst; Elizabeth McEvoy; William M Gallagher; Rustom P Manecksha; Colin S Cooper; Daniel S Brewer; Bharati Bapat; Martin G Sanda; Jeremy Clark; Antoinette S Perry
Journal:  JCO Precis Oncol       Date:  2019-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.